Casey McPherson: Why 95% of Rare Genetic Diseases Have Zero FDA-Approved Treatments, and What AlphaRose Is Doing About It
There is a medicine access problem emerging for millions of patients. More than 10,000 rare diseases have been…
Dr. Stella Vnook: How to Build and Scale Biotech Ventures Globally
Bringing a biotech breakthrough to life takes more than great science. The real work starts when a promising…